In this study, we identified the clinical significance and the predominant role of histone methyltransferase G9a depletion or inactivation of G9a, which suppresses in vitro cell growth and in vivo tumorigenecity, findings that suggest G9a provides the growth advantage of HNSCC. Here, PRDM9 is linked to head and neck squamous cell carcinoma.